Sciencons AS

Norway

Back to Profile

1-29 of 29 for Sciencons AS Sort by
Query
Aggregations
Jurisdiction
        United States 20
        World 5
        Canada 4
Date
New (last 4 weeks) 2
2026 July 2
2026 (YTD) 2
2025 9
2024 4
See more
IPC Class
G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes 15
G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers 13
G21F 5/018 - Syringe shields or holders 13
A61K 51/04 - Organic compounds 10
A61K 51/10 - Antibodies or immunoglobulinsFragments thereof 7
See more
Status
Pending 13
Registered / In Force 16
Found results for  patents

1.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Application Number 19574607
Status Pending
Filing Date 2026-03-23
First Publication Date 2026-07-30
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

2.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Application Number 19574627
Status Pending
Filing Date 2026-03-23
First Publication Date 2026-07-30
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

3.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Application Number 19262158
Status Pending
Filing Date 2025-07-08
First Publication Date 2025-10-30
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

4.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Application Number 19262147
Status Pending
Filing Date 2025-07-08
First Publication Date 2025-10-30
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

5.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Application Number 19262153
Status Pending
Filing Date 2025-07-08
First Publication Date 2025-10-30
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

6.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Application Number 18940734
Status Pending
Filing Date 2024-11-07
First Publication Date 2025-06-26
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

7.

Production Of Highly Purified 212PB

      
Application Number 18940751
Status Pending
Filing Date 2024-11-07
First Publication Date 2025-06-26
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

8.

212Pb

      
Application Number 19076415
Grant Number 12406776
Status In Force
Filing Date 2025-03-11
First Publication Date 2025-06-26
Grant Date 2025-09-02
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

9.

Production of Highly Purified 212PB

      
Application Number 18940735
Status Pending
Filing Date 2024-11-07
First Publication Date 2025-06-19
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

10.

COMPLEXES FOR CANCER TREATMENT AND IMAGING

      
Application Number 18729758
Status Pending
Filing Date 2023-01-20
First Publication Date 2025-03-27
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to complexes comprising a PSMA targeting compound linked to a radionuclide such as 47Sc, 111In, 161Tb. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications, including in the treatment of cancer as well as in monitoring and diagnostics.

IPC Classes  ?

11.

Production of highly purified 212PB

      
Application Number 18942340
Grant Number 12394533
Status In Force
Filing Date 2024-11-08
First Publication Date 2025-02-27
Grant Date 2025-08-19
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

12.

Production of highly purified 212PB

      
Application Number 18680605
Grant Number 12249437
Status In Force
Filing Date 2024-05-31
First Publication Date 2024-11-28
Grant Date 2025-03-11
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

13.

Production of highly purified 212PB

      
Application Number 18680372
Grant Number 12567511
Status In Force
Filing Date 2024-05-31
First Publication Date 2024-10-03
Grant Date 2026-03-03
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy H.

Abstract

212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

14.

COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE

      
Application Number 18628420
Status Pending
Filing Date 2024-04-05
First Publication Date 2024-07-25
Owner Sciencons AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to complexes comprising a prostate-specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.

IPC Classes  ?

  • C07F 7/24 - Lead compounds
  • A61K 51/04 - Organic compounds
  • A61P 35/00 - Antineoplastic agents
  • A61P 35/04 - Antineoplastic agents specific for metastasis
  • C07B 59/00 - Introduction of isotopes of elements into organic compounds
  • C07F 3/00 - Compounds containing elements of Groups 2 or 12 of the Periodic Table
  • C07F 9/94 - Bismuth compounds

15.

Complex comprising a PSMA-targeting compound linked to a lead or thorium radionuclide

      
Application Number 18505688
Grant Number 12297218
Status In Force
Filing Date 2023-11-09
First Publication Date 2024-06-06
Grant Date 2025-05-13
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to complexes comprising a prostate-specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.

IPC Classes  ?

  • C07F 7/24 - Lead compounds
  • A61K 51/04 - Organic compounds
  • A61P 35/00 - Antineoplastic agents
  • A61P 35/04 - Antineoplastic agents specific for metastasis
  • C07B 59/00 - Introduction of isotopes of elements into organic compounds
  • C07F 3/00 - Compounds containing elements of Groups 2 or 12 of the Periodic Table
  • C07F 9/94 - Bismuth compounds

16.

COMPLEXES FOR CANCER TREATMENT AND IMAGING

      
Application Number EP2023051355
Publication Number 2023/139203
Status In Force
Filing Date 2023-01-20
Publication Date 2023-07-27
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to complexes comprising a PSMA targeting compound linked to a radionuclide such as 47Sc, 111In, 161Tb. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications, including in the treatment of cancer as well as in monitoring and diagnostics.

IPC Classes  ?

17.

212Pb

      
Application Number 17756802
Grant Number 12125603
Status In Force
Filing Date 2020-12-04
First Publication Date 2023-01-19
Grant Date 2024-10-22
Owner Sciencons AS (Norway)
Inventor Larsen, Roy H.

Abstract

212Pb high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
  • G21F 5/018 - Syringe shields or holders

18.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Document Number 03160031
Status Pending
Filing Date 2020-12-04
Open to Public Date 2021-06-10
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising212Pb on the walls obtained from a212Pb precursor isotope source. The invention provides an improved system and method for producing212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • A61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes

19.

PRODUCTION OF HIGHLY PURIFIED 212PB

      
Application Number EP2020084701
Publication Number 2021/110950
Status In Force
Filing Date 2020-12-04
Publication Date 2021-06-10
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy, H.

Abstract

The present invention relates to assemblies and method for obtaining a container comprising212Pb on the walls obtained from a212Pb precursor isotope source. The invention provides an improved system and method for producing212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.

IPC Classes  ?

  • G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
  • A61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes

20.

212Pb labeled monoclonal antibodies

      
Application Number 16307811
Grant Number 11306038
Status In Force
Filing Date 2017-06-23
First Publication Date 2019-06-27
Grant Date 2022-04-19
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to the generation of lead-212 for therapeutic use. Specifically, are methods related to the generation of lead-212 based radio labelled proteins, such as radioimmunoconjugates, embodiments of the present invention.

IPC Classes  ?

  • A61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo
  • A61M 36/14 - Radioactive dressings
  • C07B 59/00 - Introduction of isotopes of elements into organic compounds
  • A61K 51/10 - Antibodies or immunoglobulinsFragments thereof

21.

COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE

      
Document Number 03085205
Status Pending
Filing Date 2018-12-13
Open to Public Date 2019-06-20
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to complexes comprising a prostate- specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.

IPC Classes  ?

  • A61K 51/04 - Organic compounds
  • A61P 35/00 - Antineoplastic agents
  • A61P 35/04 - Antineoplastic agents specific for metastasis
  • C07D 257/02 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

22.

COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE

      
Application Number EP2018084738
Publication Number 2019/115684
Status In Force
Filing Date 2018-12-13
Publication Date 2019-06-20
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to complexes comprising a prostate- specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.

IPC Classes  ?

23.

Lead and thorium compounds

      
Application Number 16219072
Grant Number 10377778
Status In Force
Filing Date 2018-12-13
First Publication Date 2019-06-13
Grant Date 2019-08-13
Owner Sciencons AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

227Th. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.

IPC Classes  ?

  • C07F 7/24 - Lead compounds
  • C07F 3/00 - Compounds containing elements of Groups 2 or 12 of the Periodic Table
  • C07F 9/94 - Bismuth compounds
  • A61P 35/04 - Antineoplastic agents specific for metastasis
  • C07B 59/00 - Introduction of isotopes of elements into organic compounds
  • A61K 51/04 - Organic compounds
  • A61P 35/00 - Antineoplastic agents

24.

Radiopharmaceutical solutions with advantageous properties

      
Application Number 15553298
Grant Number 10434198
Status In Force
Filing Date 2016-02-24
First Publication Date 2018-02-01
Grant Date 2019-10-08
Owner Sciencons AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

224Ra based solutions for medial treatments.

IPC Classes  ?

  • A61K 51/10 - Antibodies or immunoglobulinsFragments thereof
  • A61K 51/02 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier
  • A61K 51/04 - Organic compounds
  • A61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes

25.

PREPARATION OF 212PB LABELED MONOCLONAL ANTIBODIES

      
Document Number 03026599
Status Pending
Filing Date 2017-06-23
Open to Public Date 2017-12-28
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to the generation of lead-212 for therapeutic use. Specifically, are methods related to the generation of lead-212 based radio labelled proteins, such as radioimmunoconjugates, embodiments of the present invention.

IPC Classes  ?

  • A61K 51/10 - Antibodies or immunoglobulinsFragments thereof

26.

PREPARATION OF 212PB LABELED MONOCLONAL ANTIBODIES

      
Application Number EP2017065508
Publication Number 2017/220767
Status In Force
Filing Date 2017-06-23
Publication Date 2017-12-28
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to the generation of lead-212 for therapeutic use. Specifically, are methods related to the generation of lead-212 based radio labelled proteins, such as radioimmunoconjugates, embodiments of the present invention.

IPC Classes  ?

  • A61K 51/10 - Antibodies or immunoglobulinsFragments thereof

27.

RADIOPHARMACEUTICAL SOLUTIONS WITH ADVANTAGEOUS PROPERTIES

      
Document Number 02973644
Status In Force
Filing Date 2016-02-24
Open to Public Date 2016-09-01
Grant Date 2023-09-19
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

The present invention relates to radiopharmaceutical compositions comprising the mother nuclide 224Ra, its daughter nuclide 212Pb, and a complexing agent that complexes with the daughter nuclide. The use of targeted chelate scavengers for 224Ra daughter nuclide opens up the possibility for using 224Ra based solutions for medical treatments.

IPC Classes  ?

28.

RADIOPHARMACEUTICAL SOLUTIONS WITH ADVANTAGEOUS PROPERTIES

      
Application Number EP2016053874
Publication Number 2016/135200
Status In Force
Filing Date 2016-02-24
Publication Date 2016-09-01
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy, Hartvig

Abstract

The present invention relates to radiopharmaceutical compositions comprising the mother nuclide 224Ra, its daughter nuclide 212Pb, and a complexing agent that complexes with the daughter nuclide. The use of targeted chelate scavengers for 224Ra daughter nuclide opens up the possibility for using 224Ra based solutions for medical treatments.

IPC Classes  ?

29.

Radiopharmaceutical solutions with advantageous properties

      
Application Number 14632849
Grant Number 09433690
Status In Force
Filing Date 2015-02-26
First Publication Date 2016-09-01
Grant Date 2016-09-06
Owner SCIENCONS AS (Norway)
Inventor Larsen, Roy Hartvig

Abstract

224Ra based solutions for medical treatments.

IPC Classes  ?

  • A61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo
  • A61M 36/14 - Radioactive dressings
  • A61K 51/10 - Antibodies or immunoglobulinsFragments thereof